000 | 02104cam a2200325 a 4500 | ||
---|---|---|---|
003 | EG-GiCUC | ||
008 | 141012s2013 ua f m 000 0 eng d | ||
040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
041 | 0 | _aeng | |
049 | _aDeposite | ||
097 | _aM.Sc | ||
099 | _aCai01.11.23.M.Sc.2013.Ib.C | ||
100 | 0 | _aIbrahim Mohamed Sherif ELzawahry | |
245 | 1 | 0 |
_aChanges in survival in locally advanced laryngeal carcinoma over past three decades / _cIbrahim Mohamed Sherif ELzawahry ; Supervised Eman Abdulhady , Hanan Seleim Mosalum , Tamer Elnahas |
246 | 1 | 5 | _aنمط التغيير فى أمد الحياة فى مرضى سرطان الحنجرة المتقدمة على مدى ثلاثة عقود |
260 |
_aCairo : _bIbrahim Mohamed Sherif ELzawahry , _c2013 |
||
300 |
_a77 P. ; _c25cm |
||
502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Oncology (clinical) | ||
520 | _aAccording to the results of our study and taking into account the possibility of existence of dysfunctional larynx following radiotherapy as primary treatment modality in patients with advanced laryngeal cancer, we can conclude that total laryngectomy and ipsilateral or bilateral neck dissection followed by postoperative radiotherapy should be considered as a recommendable treatment approach in patients with resectable advanced laryngeal cancer. In order to improve treatment results in terms of LRC and OS and following evidence - based treatment recommendations for patients with advanced laryngeal cancer whose initial treatment is radical surgery, we strongly advocate the acceptance of postoperative concurrent chemoradiotherapy in cases with surgical specimen demonstrating high - risk pathological features | ||
530 | _aIssued also as CD | ||
653 | 4 | _aEpidemiology | |
653 | 4 | _aLocally advanced cancer larynx | |
653 | 4 | _aTherapeutic approach | |
700 | 0 |
_aEman Abdulhady , _eSupervisor |
|
700 | 0 |
_aHanan Seleim Mosalum , _eSupervisor |
|
700 | 0 |
_aTamer Elnahas , _eSupervisor |
|
905 |
_aNazla _eRevisor |
||
905 |
_aSamia _eCataloger |
||
942 |
_2ddc _cTH |
||
999 |
_c47736 _d47736 |